Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways
Laure‐Alix Clerbaux, Julija Filipovska, Amalia Muñoz, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5400-5400
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

The Role of Gut Dysbiosis in the Loss of Intestinal Immune Cell Functions and Viral Pathogenesis
Farzaneh Fakharian, Siva Thirugnanam, David A. Welsh, et al.
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1849-1849
Open Access | Times Cited: 36
Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID
A. Satyanarayan Naidu, Chin‐Kun Wang, Pingfan Rao, et al.
npj Science of Food (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 8
The Contribution of Diet Therapy and Probiotics in the Treatment of Sarcopenia Induced by Prolonged Immobilization Caused by the COVID-19 Pandemic
Carmen Delia Nistor-Cseppento, Titus David Moga, Alexa Florina Bungău, et al.
Nutrients (2022) Vol. 14, Iss. 21, pp. 4701-4701
Open Access | Times Cited: 29
Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19
Laure‐Alix Clerbaux, Sally A. Mayasich, Amalia Muñoz, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5691-5691
Open Access | Times Cited: 19
Advances in Animal Models and Cutting-Edge Research in Alternatives: Proceedings of the Third International Conference on 3Rs Research and Progress, Vishakhapatnam, 2022
Nikita Narayan Naik, Bharadwaja Vadloori, Suresh Poosala, et al.
Alternatives to Laboratory Animals (2023) Vol. 51, Iss. 4, pp. 263-288
Open Access | Times Cited: 10
Beyond chemicals: Opportunities and challenges of integrating non-chemical stressors in adverse outcome pathways
Laure‐Alix Clerbaux, Julija Filipovska, Penny Nymark, et al.
ALTEX (2023)
Open Access | Times Cited: 9
Signatures of disease outcome severity in the intestinal fungal and bacterial microbiome of COVID-19 patients
Fernando Rizzello, Elisa Viciani, Paolo Gionchetti, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
Infection with SARS-CoV-2 Is Associated with Elevated Levels of IP-10, MCP-1, and IL-13 in Sepsis Patients
Tanja Eichhorn, Silke Huber, René Weiss, et al.
Diagnostics (2023) Vol. 13, Iss. 6, pp. 1069-1069
Open Access | Times Cited: 7
Community-acquired bacterial coinfections and COVID-19
Michael J. Patton, Amit Gaggar, Matthew Might, et al.
Physiological Reviews (2023) Vol. 104, Iss. 1, pp. 1-21
Closed Access | Times Cited: 7
CIAO: a living experiment in interdisciplinary large-scale collaboration facilitated by the Adverse Outcome Pathway framework
Annamaria Carusi, Julija Filipovska, Clemens Wittwehr, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 6
The Effect of COVID-19 on Gut Microbiota: Exploring the Complex Interplay and Implications for Human Health
Shamima Akter, Sadia Tasnim, Rashu Barua, et al.
Gastrointestinal Disorders (2023) Vol. 5, Iss. 3, pp. 340-355
Open Access | Times Cited: 6
Modulation of gut microbiota as a potential therapy to manipulate drug-induced hepatic damage in COVID-19 patients
Khansa Ahsan, Munir Ahmad Anwar, Nayla Munawar
World Journal of Gastroenterology (2023) Vol. 29, Iss. 11, pp. 1708-1720
Open Access | Times Cited: 5
Gut Microbiota and Immune System in Necrotizing Enterocolitis and Related Sepsis
Emilio Jirillo, Skënder Topi, Ioannis Alexandros Charitos, et al.
Gastrointestinal Disorders (2024) Vol. 6, Iss. 2, pp. 431-445
Open Access | Times Cited: 1
Modulatory role of Faecalibacterium on insulin resistance and coagulation in patients with post-viral long haulers depending on adiposity
Amanda Cuevas‐Sierra, Lourdes Chero‐Sandoval, Andrea Higuera‐Gómez, et al.
iScience (2024) Vol. 27, Iss. 8, pp. 110450-110450
Open Access | Times Cited: 1
ML-based predictive gut microbiome analysis for health assessment
Manel Gil Sorribes, Gabriele Leoni, Antonio Puertas Gallardo, et al.
Procedia Computer Science (2024) Vol. 239, pp. 1452-1459
Open Access | Times Cited: 1
An overview of immune safety avatar: mimicking the effects of immunomodulatory therapies on the immune system
Vanessa Neuhaus, Laure‐Alix Clerbaux, Katherina Sewald
Journal of Immunotoxicology (2024) Vol. 21, Iss. sup1
Open Access | Times Cited: 1
Gut microbiota, malnutrition, and immunity: COVID-19’s confounding triad
Anna Creus-Cuadros, M. Mahebali Tabusi, Tannia Valeria Carpio-Arias, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 6, pp. 851-855
Open Access | Times Cited: 3
Development and management of gastrointestinal symptoms in long-term COVID-19
Kai-Yue He, Xin‐Yuan Lei, Lei Zhang, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 3
Report of the 3rd and 4th Mystery of Reactive Oxygen Species Conference
Shihori Tanabe
ALTEX (2023), pp. 689-693
Open Access | Times Cited: 2
Building an Adverse Outcome Pathway network for COVID-19
Penny Nymark, Laure‐Alix Clerbaux, Maria João Amorim, et al.
Frontiers in Systems Biology (2024) Vol. 4
Open Access
Gut microbe–host interactions in post-COVID syndrome: a debilitating or restorative partnership?
Torsten P. M. Scheithauer, R.C. Montijn, Arnout Mieremet
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access
COVID-19 and the liver
Sanjaya K. Satapathy, Shivaram Prasad Singh, Prajna Anirvan
Elsevier eBooks (2024), pp. 1349-1383
Closed Access
COVID‐19‐associated liver injury: Adding fuel to the flame
Yingqian Wang, Min Shen, Yujia Li, et al.
Cell Biochemistry and Function (2023) Vol. 41, Iss. 8, pp. 1076-1092
Closed Access | Times Cited: 1
The Pathogenesis of Gastrointestinal, Hepatic, and Pancreatic Injury in Acute and Long Coronavirus Disease 2019 Infection
Hadar Meringer, Andrew Wang, Saurabh Mehandru
Gastroenterology Clinics of North America (2022) Vol. 52, Iss. 1, pp. 1-11
Open Access | Times Cited: 2
A Reflection of Metabolic Syndrome through the Window of COVID-19
Liam Pock Ho, Chuen Wen Tan, Heng Joo Ng, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1966-1966
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top